RBT-1 reduces blood product utilization in patients undergoing nonemergency coronary artery bypass grafting and/or valve surgery
Authors:
Open Access
- 1 July 2024
- journal article
- research article
- Published by Elsevier in JTCVS Open
- Vol. 22, 61-64
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Effects of RBT-1 on preconditioning response biomarkers in patients undergoing coronary artery bypass graft or heart valve surgery: a multicentre, double-blind, randomised, placebo-controlled phase 2 trialeClinicalMedicine, 2024
- Intravenous iron administration before cardiac surgery reduces red blood cell transfusion in patients without anaemiaBritish Journal of Anaesthesia, 2023
- Perioperative Anemia and Transfusions and Late Mortality in Coronary Artery Bypass PatientsThe Annals of Thoracic Surgery, 2022
- The 7 Pillars of Blood Conservation in Cardiac SurgeryInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2021
- Heme Oxygenase-1 at the Nexus of Endothelial Cell Fate Decision Under Oxidative StressFrontiers in Cell and Developmental Biology, 2021
- On Iron Metabolism and Its RegulationInternational Journal of Molecular Sciences, 2021
- Intraoperative Autologous Blood Donation Leads to Fewer Transfusions in Cardiac SurgeryThe Annals of Thoracic Surgery, 2019
- Effects of Blood Transfusion on Cause-Specific Late Mortality After Coronary Artery Bypass Grafting—Less Is MoreThe Annals of Thoracic Surgery, 2016
- Decrease in Red Blood Cell Deformability Caused by Hypothermia, Hemodilution, and Mechanical StressASAIO Journal, 1999
- The platelet in cardiopulmonary bypassThe Annals of Thoracic Surgery, 1998